Table 3.
Results from various authors as to HPV identification in the oral cavity and oropharynx focal epithelial hyperplasia.
| Year | Investigator | Method | #.P/#.C | % | HPV type |
|---|---|---|---|---|---|
| 1984 | Syrjänen27 | IHQ | 1/1 | (100) | HPV + |
| 1987 | Hernandez-Jauregui et al.35 | SB | 7/7 | (100) | 13 |
| 1989 | Garlick et al.37 | SB | 4/4 | (100) | 13(75%), 32(25%) |
| 1989 | Henke et al.38 | ISH | 16/17 | (95) | 13(59%), 32(35%) |
| 1991 | Padayachee & Van Wyk36 | IHQ | 7/18 | (39) | HPV + |
| ISH | 15/18 | (83) | 32 (60%), 13(33%) | ||
| 11 (7%) | |||||
| 2002 | Schwenger et al.76 | PCR | 5/5 | (100) | 13(20%) e 32(60%) |
#= number; P = positives; C = cases; IHQ = immunohistochemistry; ISH = in situ hybridization; SB = Southern blot hybridization; PCR = polymerase chain reaction; HPV + = positive human papillomavirus.